Chickenpox vaccine, also known as varicella vaccine, is a vaccine that protects against chickenpox.One dose of this vaccine prevents 100% of severe disease and 95% of moderate disease. Varicella vaccine is made up of Oka strain of live attenuated virus. This vaccine is safe and constitutes rare severe side effects. Moreover, varicella vaccine is 7090% effective in preventing varicella. We mainly focus on live attenuated varicella vaccine in this report.

The global market for Chickenpox Vaccine was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Chickenpox Vaccine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Chickenpox Vaccine by region & country, by Type, and by Application.

The Chickenpox Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chickenpox Vaccine.

Market Segmentation

Scope of Chickenpox Vaccine - Market Report

Report Metric	Details
Report Name	Chickenpox Vaccine - Market
CAGR	5%
Segment by Type:	Monovalent Vaccine Combination Vaccine
Segment by Application	Kids Injection Adults Injection
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Merck, GSK, Shanghai Institute, BCHT, Changsheng, Keygen, Green Cross, Biken
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Chickenpox Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Chickenpox Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Chickenpox Vaccine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Chickenpox Vaccine - Market report?

Ans: The main players in the Chickenpox Vaccine - Market are Merck, GSK, Shanghai Institute, BCHT, Changsheng, Keygen, Green Cross, Biken

What are the Application segmentation covered in the Chickenpox Vaccine - Market report?

Ans: The Applications covered in the Chickenpox Vaccine - Market report are Kids Injection, Adults Injection

What are the Type segmentation covered in the Chickenpox Vaccine - Market report?

Ans: The Types covered in the Chickenpox Vaccine - Market report are Monovalent Vaccine, Combination Vaccine

1 Market Overview

1.1 Chickenpox Vaccine Product Introduction

1.2 Global Chickenpox Vaccine Market Size Forecast

1.2.1 Global Chickenpox Vaccine Sales Value (2019-2030)

1.2.2 Global Chickenpox Vaccine Sales Volume (2019-2030)

1.2.3 Global Chickenpox Vaccine Sales Price (2019-2030)

1.3 Chickenpox Vaccine Market Trends & Drivers

1.3.1 Chickenpox Vaccine Industry Trends

1.3.2 Chickenpox Vaccine Market Drivers & Opportunity

1.3.3 Chickenpox Vaccine Market Challenges

1.3.4 Chickenpox Vaccine Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Chickenpox Vaccine Players Revenue Ranking (2023)

2.2 Global Chickenpox Vaccine Revenue by Company (2019-2024)

2.3 Global Chickenpox Vaccine Players Sales Volume Ranking (2023)

2.4 Global Chickenpox Vaccine Sales Volume by Company Players (2019-2024)

2.5 Global Chickenpox Vaccine Average Price by Company (2019-2024)

2.6 Key Manufacturers Chickenpox Vaccine Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Chickenpox Vaccine Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Chickenpox Vaccine

2.9 Chickenpox Vaccine Market Competitive Analysis

2.9.1 Chickenpox Vaccine Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Chickenpox Vaccine Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chickenpox Vaccine as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Monovalent Vaccine

3.1.2 Combination Vaccine

3.2 Global Chickenpox Vaccine Sales Value by Type

3.2.1 Global Chickenpox Vaccine Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Chickenpox Vaccine Sales Value, by Type (2019-2030)

3.2.3 Global Chickenpox Vaccine Sales Value, by Type (%) (2019-2030)

3.3 Global Chickenpox Vaccine Sales Volume by Type

3.3.1 Global Chickenpox Vaccine Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Chickenpox Vaccine Sales Volume, by Type (2019-2030)

3.3.3 Global Chickenpox Vaccine Sales Volume, by Type (%) (2019-2030)

3.4 Global Chickenpox Vaccine Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Kids Injection

4.1.2 Adults Injection

4.2 Global Chickenpox Vaccine Sales Value by Application

4.2.1 Global Chickenpox Vaccine Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Chickenpox Vaccine Sales Value, by Application (2019-2030)

4.2.3 Global Chickenpox Vaccine Sales Value, by Application (%) (2019-2030)

4.3 Global Chickenpox Vaccine Sales Volume by Application

4.3.1 Global Chickenpox Vaccine Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Chickenpox Vaccine Sales Volume, by Application (2019-2030)

4.3.3 Global Chickenpox Vaccine Sales Volume, by Application (%) (2019-2030)

4.4 Global Chickenpox Vaccine Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Chickenpox Vaccine Sales Value by Region

5.1.1 Global Chickenpox Vaccine Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Chickenpox Vaccine Sales Value by Region (2019-2024)

5.1.3 Global Chickenpox Vaccine Sales Value by Region (2025-2030)

5.1.4 Global Chickenpox Vaccine Sales Value by Region (%), (2019-2030)

5.2 Global Chickenpox Vaccine Sales Volume by Region

5.2.1 Global Chickenpox Vaccine Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Chickenpox Vaccine Sales Volume by Region (2019-2024)

5.2.3 Global Chickenpox Vaccine Sales Volume by Region (2025-2030)

5.2.4 Global Chickenpox Vaccine Sales Volume by Region (%), (2019-2030)

5.3 Global Chickenpox Vaccine Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Chickenpox Vaccine Sales Value, 2019-2030

5.4.2 North America Chickenpox Vaccine Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Chickenpox Vaccine Sales Value, 2019-2030

5.5.2 Europe Chickenpox Vaccine Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Chickenpox Vaccine Sales Value, 2019-2030

5.6.2 Asia Pacific Chickenpox Vaccine Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Chickenpox Vaccine Sales Value, 2019-2030

5.7.2 South America Chickenpox Vaccine Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Chickenpox Vaccine Sales Value, 2019-2030

5.8.2 Middle East & Africa Chickenpox Vaccine Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Chickenpox Vaccine Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Chickenpox Vaccine Sales Value

6.2.1 Key Countries/Regions Chickenpox Vaccine Sales Value, 2019-2030

6.2.2 Key Countries/Regions Chickenpox Vaccine Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Chickenpox Vaccine Sales Value, 2019-2030

6.3.2 United States Chickenpox Vaccine Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Chickenpox Vaccine Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Chickenpox Vaccine Sales Value, 2019-2030

6.4.2 Europe Chickenpox Vaccine Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Chickenpox Vaccine Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Chickenpox Vaccine Sales Value, 2019-2030

6.5.2 China Chickenpox Vaccine Sales Value by Type (%), 2023 VS 2030

6.5.3 China Chickenpox Vaccine Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Chickenpox Vaccine Sales Value, 2019-2030

6.6.2 Japan Chickenpox Vaccine Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Chickenpox Vaccine Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Chickenpox Vaccine Sales Value, 2019-2030

6.7.2 South Korea Chickenpox Vaccine Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Chickenpox Vaccine Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Chickenpox Vaccine Sales Value, 2019-2030

6.8.2 Southeast Asia Chickenpox Vaccine Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Chickenpox Vaccine Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Chickenpox Vaccine Sales Value, 2019-2030

6.9.2 India Chickenpox Vaccine Sales Value by Type (%), 2023 VS 2030

6.9.3 India Chickenpox Vaccine Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Merck

7.1.1 Merck Company Information

7.1.2 Merck Introduction and Business Overview

7.1.3 Merck Chickenpox Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Merck Chickenpox Vaccine Product Offerings

7.1.5 Merck Recent Development

7.2 GSK

7.2.1 GSK Company Information

7.2.2 GSK Introduction and Business Overview

7.2.3 GSK Chickenpox Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.2.4 GSK Chickenpox Vaccine Product Offerings

7.2.5 GSK Recent Development

7.3 Shanghai Institute

7.3.1 Shanghai Institute Company Information

7.3.2 Shanghai Institute Introduction and Business Overview

7.3.3 Shanghai Institute Chickenpox Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Shanghai Institute Chickenpox Vaccine Product Offerings

7.3.5 Shanghai Institute Recent Development

7.4 BCHT

7.4.1 BCHT Company Information

7.4.2 BCHT Introduction and Business Overview

7.4.3 BCHT Chickenpox Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.4.4 BCHT Chickenpox Vaccine Product Offerings

7.4.5 BCHT Recent Development

7.5 Changsheng

7.5.1 Changsheng Company Information

7.5.2 Changsheng Introduction and Business Overview

7.5.3 Changsheng Chickenpox Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Changsheng Chickenpox Vaccine Product Offerings

7.5.5 Changsheng Recent Development

7.6 Keygen

7.6.1 Keygen Company Information

7.6.2 Keygen Introduction and Business Overview

7.6.3 Keygen Chickenpox Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Keygen Chickenpox Vaccine Product Offerings

7.6.5 Keygen Recent Development

7.7 Green Cross

7.7.1 Green Cross Company Information

7.7.2 Green Cross Introduction and Business Overview

7.7.3 Green Cross Chickenpox Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Green Cross Chickenpox Vaccine Product Offerings

7.7.5 Green Cross Recent Development

7.8 Biken

7.8.1 Biken Company Information

7.8.2 Biken Introduction and Business Overview

7.8.3 Biken Chickenpox Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Biken Chickenpox Vaccine Product Offerings

7.8.5 Biken Recent Development

8 Industry Chain Analysis

8.1 Chickenpox Vaccine Industrial Chain

8.2 Chickenpox Vaccine Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Chickenpox Vaccine Sales Model

8.5.2 Sales Channel

8.5.3 Chickenpox Vaccine Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Chickenpox Vaccine Market Trends

Table 2. Chickenpox Vaccine Market Drivers & Opportunity

Table 3. Chickenpox Vaccine Market Challenges

Table 4. Chickenpox Vaccine Market Restraints

Table 5. Global Chickenpox Vaccine Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Chickenpox Vaccine Revenue Market Share by Company (2019-2024)

Table 7. Global Chickenpox Vaccine Sales Volume by Company (2019-2024) & (K Doses)

Table 8. Global Chickenpox Vaccine Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Chickenpox Vaccine Price by Company (2019-2024) & (USD/Dose)

Table 10. Key Manufacturers Chickenpox Vaccine Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Chickenpox Vaccine Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Chickenpox Vaccine

Table 13. Global Chickenpox Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chickenpox Vaccine as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Chickenpox Vaccine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Chickenpox Vaccine Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Chickenpox Vaccine Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Chickenpox Vaccine Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Chickenpox Vaccine Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Chickenpox Vaccine Sales Volume by Type: 2019 VS 2023 VS 2030 (K Doses)

Table 22. Global Chickenpox Vaccine Sales Volume by Type (2019-2024) & (K Doses)

Table 23. Global Chickenpox Vaccine Sales Volume by Type (2025-2030) & (K Doses)

Table 24. Global Chickenpox Vaccine Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Chickenpox Vaccine Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Chickenpox Vaccine Price by Type (2019-2024) & (USD/Dose)

Table 27. Global Chickenpox Vaccine Price by Type (2025-2030) & (USD/Dose)

Table 28. Global Chickenpox Vaccine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Chickenpox Vaccine Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Chickenpox Vaccine Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Chickenpox Vaccine Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Chickenpox Vaccine Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Chickenpox Vaccine Sales Volume by Application: 2019 VS 2023 VS 2030 (K Doses)

Table 34. Global Chickenpox Vaccine Sales Volume by Application (2019-2024) & (K Doses)

Table 35. Global Chickenpox Vaccine Sales Volume by Application (2025-2030) & (K Doses)

Table 36. Global Chickenpox Vaccine Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Chickenpox Vaccine Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Chickenpox Vaccine Price by Application (2019-2024) & (USD/Dose)

Table 39. Global Chickenpox Vaccine Price by Application (2025-2030) & (USD/Dose)

Table 40. Global Chickenpox Vaccine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Chickenpox Vaccine Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Chickenpox Vaccine Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Chickenpox Vaccine Sales Value by Region (2019-2024) & (%)

Table 44. Global Chickenpox Vaccine Sales Value by Region (2025-2030) & (%)

Table 45. Global Chickenpox Vaccine Sales Volume by Region (K Doses): 2019 VS 2023 VS 2030

Table 46. Global Chickenpox Vaccine Sales Volume by Region (2019-2024) & (K Doses)

Table 47. Global Chickenpox Vaccine Sales Volume by Region (2025-2030) & (K Doses)

Table 48. Global Chickenpox Vaccine Sales Volume by Region (2019-2024) & (%)

Table 49. Global Chickenpox Vaccine Sales Volume by Region (2025-2030) & (%)

Table 50. Global Chickenpox Vaccine Average Price by Region (2019-2024) & (USD/Dose)

Table 51. Global Chickenpox Vaccine Average Price by Region (2025-2030) & (USD/Dose)

Table 52. Key Countries/Regions Chickenpox Vaccine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Chickenpox Vaccine Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Chickenpox Vaccine Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Chickenpox Vaccine Sales Volume, (2019-2024) & (K Doses)

Table 56. Key Countries/Regions Chickenpox Vaccine Sales Volume, (2025-2030) & (K Doses)

Table 57. Merck Company Information

Table 58. Merck Introduction and Business Overview

Table 59. Merck Chickenpox Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 60. Merck Chickenpox Vaccine Product Offerings

Table 61. Merck Recent Development

Table 62. GSK Company Information

Table 63. GSK Introduction and Business Overview

Table 64. GSK Chickenpox Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 65. GSK Chickenpox Vaccine Product Offerings

Table 66. GSK Recent Development

Table 67. Shanghai Institute Company Information

Table 68. Shanghai Institute Introduction and Business Overview

Table 69. Shanghai Institute Chickenpox Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 70. Shanghai Institute Chickenpox Vaccine Product Offerings

Table 71. Shanghai Institute Recent Development

Table 72. BCHT Company Information

Table 73. BCHT Introduction and Business Overview

Table 74. BCHT Chickenpox Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 75. BCHT Chickenpox Vaccine Product Offerings

Table 76. BCHT Recent Development

Table 77. Changsheng Company Information

Table 78. Changsheng Introduction and Business Overview

Table 79. Changsheng Chickenpox Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 80. Changsheng Chickenpox Vaccine Product Offerings

Table 81. Changsheng Recent Development

Table 82. Keygen Company Information

Table 83. Keygen Introduction and Business Overview

Table 84. Keygen Chickenpox Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 85. Keygen Chickenpox Vaccine Product Offerings

Table 86. Keygen Recent Development

Table 87. Green Cross Company Information

Table 88. Green Cross Introduction and Business Overview

Table 89. Green Cross Chickenpox Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 90. Green Cross Chickenpox Vaccine Product Offerings

Table 91. Green Cross Recent Development

Table 92. Biken Company Information

Table 93. Biken Introduction and Business Overview

Table 94. Biken Chickenpox Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 95. Biken Chickenpox Vaccine Product Offerings

Table 96. Biken Recent Development

Table 97. Key Raw Materials Lists

Table 98. Raw Materials Key Suppliers Lists

Table 99. Chickenpox Vaccine Downstream Customers

Table 100. Chickenpox Vaccine Distributors List

Table 101. Research Programs/Design for This Report

Table 102. Key Data Information from Secondary Sources

Table 103. Key Data Information from Primary Sources

List of Figures

Figure 1. Chickenpox Vaccine Product Picture

Figure 2. Global Chickenpox Vaccine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Chickenpox Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Chickenpox Vaccine Sales Volume (2019-2030) & (K Doses)

Figure 5. Global Chickenpox Vaccine Sales Price (2019-2030) & (USD/Dose)

Figure 6. Chickenpox Vaccine Report Years Considered

Figure 7. Global Chickenpox Vaccine Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Chickenpox Vaccine Players Sales Volume Ranking (2023) & (K Doses)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Chickenpox Vaccine Revenue in 2023

Figure 10. Chickenpox Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Monovalent Vaccine Picture

Figure 12. Combination Vaccine Picture

Figure 13. Global Chickenpox Vaccine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Chickenpox Vaccine Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Chickenpox Vaccine Sales Volume by Type (2019 VS 2023 VS 2030) & (K Doses)

Figure 16. Global Chickenpox Vaccine Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Chickenpox Vaccine Price by Type (2019-2030) & (USD/Dose)

Figure 18. Product Picture of Kids Injection

Figure 19. Product Picture of Adults Injection

Figure 20. Global Chickenpox Vaccine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 21. Global Chickenpox Vaccine Sales Value Market Share by Application, 2023 & 2030

Figure 22. Global Chickenpox Vaccine Sales Volume by Application (2019 VS 2023 VS 2030) & (K Doses)

Figure 23. Global Chickenpox Vaccine Sales Volume Market Share by Application, 2023 & 2030

Figure 24. Global Chickenpox Vaccine Price by Application (2019-2030) & (USD/Dose)

Figure 25. North America Chickenpox Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 26. North America Chickenpox Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 27. Europe Chickenpox Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 28. Europe Chickenpox Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 29. Asia Pacific Chickenpox Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 30. Asia Pacific Chickenpox Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 31. South America Chickenpox Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 32. South America Chickenpox Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 33. Middle East & Africa Chickenpox Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 34. Middle East & Africa Chickenpox Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 35. Key Countries/Regions Chickenpox Vaccine Sales Value (%), (2019-2030)

Figure 36. Key Countries/Regions Chickenpox Vaccine Sales Volume (%), (2019-2030)

Figure 37. United States Chickenpox Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 38. United States Chickenpox Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 39. United States Chickenpox Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 40. Europe Chickenpox Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 41. Europe Chickenpox Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 42. Europe Chickenpox Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 43. China Chickenpox Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 44. China Chickenpox Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 45. China Chickenpox Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 46. Japan Chickenpox Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 47. Japan Chickenpox Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 48. Japan Chickenpox Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 49. South Korea Chickenpox Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 50. South Korea Chickenpox Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 51. South Korea Chickenpox Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 52. Southeast Asia Chickenpox Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 53. Southeast Asia Chickenpox Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 54. Southeast Asia Chickenpox Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 55. India Chickenpox Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 56. India Chickenpox Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 57. India Chickenpox Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 58. Chickenpox Vaccine Industrial Chain

Figure 59. Chickenpox Vaccine Manufacturing Cost Structure

Figure 60. Channels of Distribution (Direct Sales, and Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions